Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

Yeni, P ; Cooper, D A ; Aboulker, J P ; Babiker, A G ; Carey, D ; Darbyshire, J H ; Floridia, M ; Girard, P M ; Goodall, R L ; Hooker, M H ; Mijch, A ; Meiffredy, V ; Salzberger, B

The Lancet (British edition), 2006-07, Vol.368 (9532), p.287-298 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível